Tianeptine-d6
目录号 : GC48179A neuropeptide with diverse biological activities
Sample solution is provided at 25 µL, 10mM.
Tianeptine-d6 is intended for use as an internal standard for the quantification of tianeptine by GC- or LC-MS. Tianeptine is an atypical antidepressant.1 It is an agonist of the μ-opioid receptor (MOR; EC50s = 194 and 641 nM for human and mouse receptors, respectively, in a BRET assay for G protein activation) and also has effects on the glutamate system.1,2 Tianeptine (30 mg/kg) decreases immobility in the forced swim test in wild-type, but not MOR knockout mice, indicating antidepressant-like activity dependent on MORs.3 It increases locomotor activity at a dose of 30, but not 10 mg/kg, in the open field test and increases paw withdrawal latency in the hot-plate test in mice. Tianeptine modulates AMPA receptor activity by increasing phosphorylation of the AMPA receptor GluR1 subunit in the frontal cortex and hippocampal CA3 region in mice.4 It prevents increases in glial glutamate transporter 1 (GLT-1) expression induced by chronic restraint stress in the hippocampal CA3 region in rats when administered at a dose of 10 mg/kg per day for 21 days.5 It also reverses increases in extracellular glutamate levels induced by acute restraint stress in the basolateral nucleus of the amygdala in rats.6
1.McEwen, B.S., Chattarji, S., Diamond, D.M., et al.The neurobiological properties of tianeptine (Stablon): From monoamine hypothesis to glutamatergic modulationMol. Psychiatry15(3)237-249(2010) 2.Gassaway, M.M., Rives, M.L., Kruegel, A.C., et al.The atypical antidepressant and neurorestorative agent tianeptine is a μ-opioid receptor agonistTransl. Psychiatry4e411(2014) 3.Samuels, B.A., Nautiyal, K.M., Kruegel, A.C., et al.The behavioral effects of the antidepressant tianeptine require the mu-opioid receptorNeuropsychopharmacology42(10)2052-2063(2017) 4.Svenningsson, P., Bateup, H., Qi, H., et al.Involvement of AMPA receptor phosphorylation in antidepressant actions with special reference to tianeptineEur. J. Neurosci.26(12)3509-3517(2007) 5.Reagan, L.P., Rossell, D.R., Wood, G.E., et al.Chronic restraint stress up-regulates GLT-1 mRNA and protein expression in the rat hippocampus: Reversal by tianeptineProc. Natl. Acad. Sci. U.S.A.101(7)2179-2184(2004) 6.Reznikov, L.R., Grillo, C.A., Piroli, G.G., et al.Acute stress-mediated increases in extracellular glutamate levels in the rat amygdala: Differential effects of antidepressant treatmentEur. J. Neurosci.25(10)3109-3114(2007)
Cas No. | N/A | SDF | |
Canonical SMILES | OC(CCC([2H])([2H])C([2H])([2H])C([2H])([2H])CNC(C1=C2C=C(Cl)C=C1)C(C=CC=C3)=C3N(C)S2(=O)=O)=O | ||
分子式 | C21H19D6ClN2O4S | 分子量 | 443 |
溶解度 | Methanol: soluble | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.2573 mL | 11.2867 mL | 22.5734 mL |
5 mM | 0.4515 mL | 2.2573 mL | 4.5147 mL |
10 mM | 0.2257 mL | 1.1287 mL | 2.2573 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >99.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet